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Abstract
Introduction:
It is increasingly recognized that social Isolation (SI) leads to a wide array of
behavioral and cognitive deficits. Isolation and loneliness are linked to all-cause
mortality, as well as mortality from stroke and other vascular diseases. In addition,
isolated or lonely individuals have significantly poorer cognitive and functional
outcomes following stroke and have higher rates of stroke recurrence. These
detrimental effects have also been recapitulated in animal models; animals
isolated prior to, or at the time of stroke, have larger infarcts than pair-housed mice.
However, the mechanisms mediating the effects of social factors on stroke
recovery are unknown. An emerging subtype of microglia classified as “diseaseassociated microglia (DAM)” has been implicated in the progression of
neurological diseases such as Alzheimer’s disease (AD) and amyotrophic lateral
sclerosis (ALS). MicroRNAs (miRNAs), a class of 18-25 nucleotide non-coding
RNAs, have been shown to regulate the activation of microglia from a resting state
to “disease-associated microglia (DAM)”. Preliminary work in the laboratory has
shown post-stroke SI significantly alters miRNA profiles in the brain. Targeted
miRNA-based therapies reduced pro-inflammatory cytokines and restores
functional recovery in aged male mice placed in isolation immediately after stroke.
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Based on this preliminary data and previous reports, we hypothesize that
differential expression of miRNAs may contribute to the deleterious effects of poststroke SI through effects of accumulating presence of “disease-associated
microglia”. The temporal profiles of miRNA changes were determined in mice
placed in isolation three days after stroke.
Methods:
Aged (18-20 month) C57BL/6 male mice were used to examine the detrimental
effects of post-stroke SI on miRNA profiles in the brain and to evaluate “diseaseassociated microglia (DAM)” phenotypes. Mice were randomly assigned to either
continued pair housing (PH), or single housing (SI) three days after a 60-minute
transient right middle cerebral artery occlusion (MCAO). At this time point (3d), the
infarct is complete, and equivalent between groups, avoiding potential changes
seen with differing infarct sizes. MiRNA profiling of the ipsilateral hemisphere was
assessed at three time points (post-stroke SI D1, D4, and D27) using the QIAGEN
NGS platform. Activation of “disease-associated microglia (DAM)” was determined
by flow cytometry analysis at post-stroke SI D4.
Results:
Post-stroke SI results in a significant alteration of miRNA profiles within the brain
across both acute and chronic time points. MiRNA-mRNA interactional analysis
reveals miR-466i-3p, miR-10a-5p, and miR-10b-5p as pivotal nodes within the pool
of miRNAs that interacted with the largest subset of miRNAs for post-stroke at SI
D1, D4, and D27 respectively. Downstream pathway analysis utilizing two
independent repositories showed four days of isolation results in microglial
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activation and 27 days of isolation leads to long-term depressive phenotypes (FDR
adjusted p<0.05). Independent validation cohorts demonstrated a significant
activation of microglia at post-stroke SI D4 as measured by the expression of
P2RY12 (p<0.05) on microglia. These results show that post-stroke SI results in
microglial activation.
Summary and Conclusions:
In summary, these results support our hypothesis that post-stroke SI results in the
activation of microglia that may be regulated by particular classes of miRNAs.
Studies manipulating these discovered targets are needed to determine if the
detrimental effects of SI can be reversed to enhance post-stroke recovery.
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Introduction
Ischemic stroke is initiated by the abrupt onset of energy depletion, cellular
ionic imbalances, and oxidative stress primarily from arterial occlusions within the
vasculature of the brain (Musuka et al., 2015). Phenotypic manifestations of
cerebral ischemia are clinically observed as focal neurological deficits of variable
severity of acute motor, sensory, and cognitive impairment (Samuelsson et al.,
2021, Belova et al., 2021). Upon the onset of cerebral ischemia, differential blood
supply within the cerebral environment results in an ischemic core and satellite
penumbral regions (Yang and Liu, 2021).
The importance of microglia in maintaining homeostasis within the healthy
brain and in various age-related neurodegenerative diseases are well documented
(Streit et al., 2004, Butovsky and Weiner, 2018). However, studies show conflicting
outcomes regarding the contribution of microglial activation in the onset of stroke
and its disease progression (Santiago et al., 2017, Lin et al., 2021, Shi et al., 2021).
Some reports show the transition of microglia from a resting state to an activated
one within the acute phase of ischemic stroke promotes neuronal plasticity by
mediating crosstalk and the clearance of damaged neurons (Zhang et al., 2021).
Others show microglia activation results in the exacerbation of an inflammatory
environment by transcriptional cascades leading to the acute production of
detrimental cytokines resulting in behavioral deficits and delayed cognitive
recovery in the chronic phase of ischemia (Frick et al., 2013). More recently,
comprehensive single cell RNA analysis of central nervous system (CNS) immune
cells have unraveled subtypes of microglia with distinct transcriptional and
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functional signatures (Keren-Shaul et al., 2017). Disease-associated microglia are
classified as immune cells with typical surface expression of ionized calcium
binding adaptor molecule 1 (Iba1) and Cystatin C (cst3) (Deczkowska et al., 2018).
One of these subtypes, “disease-associated microglia (DAM)” are predominantly
present in Alzheimer’s disease (AD) and amyotrophic lateral sclerosis (ALS) may
play a central role in the pathogenicity of neurodegenerative diseases (KerenShaul et al., 2017).
Disease-associated microglia were initially found in mouse models of AD
which expressed five human familial AD mutations (5XFAD) (Ajami et al., 2018)
and more recently in aging (Holtman et al., 2015). Accumulating evidence has
shown that the presence of “disease-associated microglial (DAM)” in the brain may
have mixed outcomes in disease progression and recovery thus the
characterization and identification of these cell populations are essential. Many
recent studies have suggested that there are robust markers that can identify
“disease-associated microglial (DAM)” populations that can be used in parallel with
a unique set of transcriptional signatures (Deczkowska et al., 2018). Two of these
markers are trans-membrane protein 119 (Tmem119), of unknown function in the
CNS, and the well-studied purinergic receptor, P2Y12 (P2RY12) (Bennett et al.,
2016). Single cell sequencing studies have shown the downregulation of
Tmem119 and P2RY12 expression in models of AD and ALS can identify “diseaseassociated microglia (DAM)” in the brain (Deczkowska et al., 2018). Investigating
these regulators in relation to the modulation of these microglial phenotypes postischemic injury could emerge as a new avenue for novel therapeutics.
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SI is a risk factor for a wide array of mental and psychological disorders
which significantly enhances the chance of developing neurological diseases,
especially within the aged population (House et al., 1988, Steptoe et al., 2013).
Recent pre-clinical and clinical studies have found that SI not only increases the
likelihood of having an ischemic stroke, but also exacerbates post-stroke
inflammation and worsens functional recovery (Venna et al., 2012). Social
interaction can overcome these detrimental effects of SI by promoting active
coping behaviors and initiating anti-inflammatory mechanisms in the brain and
systemically (Verma et al., 2014). Work from our laboratory has shown that mice
placed into singly housed environments post-stroke have significantly poorer
functional recovery, enhanced microglial activation, and significant astrogliosis
(Verma et al., 2014). Although SI has been consistently found to influence poststroke recovery, potential targeted interventions to mitigate these inflammatory
events leading to impaired functional and cognitive recovery are extremely limited.
MiRNAs are classified as endogenous noncoding-RNAs around 18–25
nucleotides in length that mediate post-transcriptional gene modification by
coordinately binding the 3′-untranslated regions (3′-UTR) (O'Brien et al., 2018).
They have been increasingly recognized to be an effective diagnostic marker in
stroke (Alhazzani et al., 2021). Multiple studies have shown that expression
profiles of circulating miRNAs and miRNAs in the brain are altered through
dynamic changes in the social environment that could potentially be harnessed to
recapitulate the positive aspects of social interaction (Banerjee et al., 2021).
Moreover, miRNAs have been shown to regulate microglial activation through
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targeting genes involved in inflammatory signaling cascades, cytokine production,
and transcriptional networks that determine microglia polarization (Verma et al.,
2018). Our laboratory has identified classes of miRNAs that regulate key
processes in the onset of stroke, which exacerbate inflammation induced through
the production of deleterious pro-inflammatory cytokines (Verma et al., 2018). In
addition, more recently, post-stroke mice housed in isolated environments have
altered microglial activation states acutely, which may contribute to the production
and the increased abundance of pro-inflammatory cytokines in the brain. This led
us to hypothesize that the differential expression of miRNAs may play a deleterious
role in post-stroke isolation via microglial activation.
Methods/ Materials
This chapter is based upon (Banerjee et al., 2021) and Adapted/Translated by
permission from [Anik Banerjee] : [Springer Nature] [NeuroMolecular Medicine]
[BANERJEE, A., CHOKKALLA, A. K., SHI, J. J., LEE, J., VENNA, V. R.,
VEMUGANTI, R. & MCCULLOUGH, L. D. 2021. Microarray Profiling Reveals
Distinct Circulating miRNAs in Aged Male and Female Mice Subjected to Poststroke Social Isolation. Neuromolecular Med, 23, 305-314.], [COPYRIGHT: 2021]
Animals
C57BL/6 aged male mice (18-20 months of age; National Institute on Aging,
Bethesda, MD) were acclimated for 1 month in our animal care facility prior to use.
Mice were housed in pairs for 2 weeks (2 mice/cage) with a daily compatibility
monitoring (eg, weight gain and the absence of fight wounds) as previously shown
(Verma et al., 2018). All mice were housed with 12-h light/dark schedule in a
temperature- and humidity-controlled vivarium, with ad libitum access to food and
water. Three days following middle cerebral artery occlusion (MCAO) surgery,
mice were randomly assigned to either pair housing (PH; stroke mouse continued
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to be paired with previous partner mouse); or singly housed (SI; stroke isolated).
A previous study from our laboratory assigned housing conditions immediately
following stroke (Verma et al., 2018), and data from an earlier report also showed
that pre-stroke SI, or SI at the time of stroke resulted in a significant increase in
infarction volume and in turn exacerbated stroke severity and behavioral deficits
(Venna et al., 2012). Thus, to control for infarct size we waited for three days to
place animals in their assigned housing conditions to ensure that the infarct was
complete, and that infarct size was equivalent between the groups. This
experimental paradigm ensures that differences seen are mediated by housing
conditions, not stroke size. Based on a predefined criterion, if a pair-housed stroke
mouse died, the other partner mouse was also excluded from the study. The
Institutional Animal Care and Use Committee at The University of Texas McGovern
Medical School approved all animal protocols. All studies were performed in
accordance with the guidelines provided by the National Institute of Health (NIH)
and followed RIGOR guidelines.
Transient Stroke Model
To induce middle cerebral artery (MCA) occlusion, mice were anesthetized with
isoflurane, a midline neck incision was performed to expose external carotid artery,
a 6.0 silicone rubber-coated monofilament (Doccol Corporation) was inserted into
the external carotid artery stump and advanced to the root of MCA via the internal
carotid artery and allowed to remain in place for 60-minute of occlusion. Following
60 minutes of occlusion, mice were re-anesthetized, and the monofilament suture
was removed to restore the blood flow. Once mice were awakened from
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anesthesia, the presence of an intra-ischemic deficit was evaluated. All mice were
given wet mesh daily and 1.0 ml of subcutaneous saline once a day for 3 days
following surgery. Each pair of animals were randomly assigned toward their
housing condition three days following MCA occlusion into either isolation or
continued pair housed groups (N=7-8/ group).
Euthanasia
Mice were euthanized at post-stroke SI Day 1, 4, and 27 respectively using an
overdose

of

avertin

(2,2,2-

Tribromoethanol)

injected

intraperitoneally.

Confirmation of anesthesia was done by paw pinch prior to tissue harvesting.
Following tissue harvesting from the mice, the brain and blood were removed for
analysis.
Sample Preparation for RNA Isolation and Real-Time Quantitative PCR of
miRNA
RNA extraction for qPCR was performed using Qiagen miRNeasy Mini Kit from
ipsilateral hemisphere samples from post-stroke SI day 1, 4, and 27. RNA was
stored at −80°C until analysis by QIAGEN next generation sequencing (NGS)
platform. 10 ng RNA was reverse transcribed in 10 μL reactions using the
miRCURY LNA universal real-time miRNA complementary DNA system (QIAGEN,
Germantown, MD). Resulting complementary DNA was diluted (1:50) and assayed
in miRNA ready-to-use PCR mouse miRCURY LNA SYBR green master mix
(QIAGEN) as per manufacturer’s protocol in a CFX384 Touch Real-Time PCR
Detection System (Bio-Rad).
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Quality Control, Small RNA library preparation, and Next generation
sequencing
NGS and bioinformatics analysis were conducted at QIAGEN Genomic Services.
For sample preparation, RNA was isolated using miRNeasy kit from QIAGEN as
per manufacturer’s protocol. QIAseq miRNA Library kit was utilized for library
preparation using 5 uL of RNA converted into miRNA NGS libraries. Once unique
molecular identifiers (UMIs) were attached, the RNA was converted into
complementary DNA (cDNA). Following the synthesis of cDNA, a total of 22 cycles
in PCR was used to amplify the cDNA in which PCR indices were added at the
time. Bio-Analyzer 2100 or Tape-Station 4200 from Agilent was used to perform
quality control on the library preparation. All samples prepared for the library were
pooled in an equimolar ratio based on the quality of the inserts and the
concentration of RNA/ cDNA. The pooled samples were quantified using
qualitative PCR (qPCR). Following quantification, the pooled samples were fed
into a NextSeq 500 sequencing instrument as per manufacturer’s instructions.
FASTQ files were generated using bcl2fastq (bcl2fastq (RRID:SCR_015058))
software from Illumina Inc. Processing of FASTQ files were performed using
various platforms; trimming to extract sequences from adapter and UMI raw reads
were performed by Cutadapt (1.11) (DOI:10.14806/ej.17.1.200), non-coding
mapping was performed using Bowtie2 (2.2.2) (Langmead et al., 2009) to align
reads of abundant sequences toward miRbase (Kozomara et al., 2019) reference
sequences. The criterion for mapping reads to spike-ins, abundant sequences, and
the database from miRbase are essential to have perfect matches to reference
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sequences. For mapping parameters to the genome, more than one mismatch
within the first 32 bases of the read was not allowed. Further, no indels were
allowed in the mapping. Unmapped reads were excluded from further differential
expression analysis. Differential expression analysis was performed by EdgeR
(Chen et al., 2016) statistical software package from Bioconductor for fold change
analysis within CLC Workbench (QIAGEN).
Prediction and pathways analysis of target mRNAs for differentially
expressed miRNAs
The mRNA targets of differentially expressed miRNAs were predicted using the
publicly available miRNET 2.0 tool (Chang et al., 2020), which is a comprehensive
platform with data integrated from 11 different programs (MicroT4, miRBridge,
miRMap, miRNAMap, PICTAR2, RNA22, RNAhybrid, TargetScan, miRanda,
miRDB and PITA). Target prediction tool within miRNET 2.0 (Chang et al., 2020)
for mRNA targets and differentially expressed miRNAs were utilized for node and
edge identification for miRNA-mRNA interactional network construction. KEGG
and Reactome analyses were acquired using the functional feature in miRNET 2.0
utilizing all the identified genes and the hypergeometric test.
Flow cytometry (Brain)
Brain single-cell suspension was obtained using a previously published protocol
(Honarpisheh et al., 2020, Lee et al., 2020). Briefly, mice were euthanized by i.p.
avertin injection at post-stroke SI D4 (4 days post housing manipulation and 7 days
post stroke). Following euthanasia, mice were trans-cardially perfused with 20-mL
of ice-cold PBS prior to removal of brain tissues. A midline coronal section of the
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ipsilateral hemisphere encompassing the perilesional infarct was flashed frozen in
an Eppendorf tube and stored in -80C for following RNA isolation. The leftover
brain tissue (from the ipsilateral hemisphere of both anterior and posterior
sections) was placed in complete Roswell Park Memorial Institute (RPMI) 1640
(Lonza) medium prior to mechanically and enzymatically digesting the
homogenate in Collagenase/Dispase (1 mg/mL) and DNase (10 mg/mL; Roche
Diagnostics) for 45 min at 37 °C with gentle shaking (80-100 RPM). Following
digestion, the cell suspension was filtered through a 70-μm filter. Leukocytes were
harvested from the interphase of 70–30% Percoll gradients for the brain tissue to
remove myelin. Cells were washed and blocked with mouse Fc Block (BioLegend,
Lot: B298973) before staining with primary antibody-conjugated fluorophores:
CD45-eF450 (eBioscience, Cat#: 48-0451-82, Lot: 2005853), CD11b-APC
(BioLegend, Cat#: 101212, Lot: B279418), Ly6C-PerCP-Cy5.5 (BioLegend, Cat#:
128011, Lot: 292026), Tmem119-PE-Cy7 (eBioscience, Cat#: 25-6119-82, Lot:
2210260), P2RY12-PE (BioLegend, Cat#: 848003, B298459), and MHCII-APCFire750 (BioLegend, Cat#: 107652, Lot: B301025) pre-conjugated antibodies and
Zombie Aqua (BioLegend, Cat#: 423102, Lot: B300004) to assess for cell viability.
To minimize experimental variability, cell isolation and immunostaining steps were
carried out all at once for both housing conditions (PH and SI). Data were acquired
on Cytoflex-S (Beckman Coulter) and analyzed using FlowJo (Treestar Inc.). No
less than 100,000 events were recorded for each sample. Unstained controls and
tissue-matched fluorescence minus one (FMO) were used to aid in the gating
strategy. Median fluorescence intensity (MFI) reported as arbitrary fluorescence
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units [a.f.u] was used as measure of expression level on corresponding cell
populations of interest.
Statistics
The evaluation of data and graphical representations was performed utilizing
Graph Pad Prism 8.4.2 software, San Diego, California USA, www.graphpad.com.
The data are shown as the means +/- standard error of the mean (SEM). Student
t test was used for two-group comparisons set as non-parametric measures. A pvalue of less than 0.05 was considered as a significant measure for two sample
analyses. A false discovery rate (FDR) adjusted p-value of less than 0.05 was
considered as a significant measure for multiple hypothesis testing.
Results
This chapter is based upon (Banerjee et al., 2021) and Adapted/Translated by
permission from [Anik Banerjee] : [Springer Nature] [NeuroMolecular Medicine]
[BANERJEE, A., CHOKKALLA, A. K., SHI, J. J., LEE, J., VENNA, V. R.,
VEMUGANTI, R. & MCCULLOUGH, L. D. 2021. Microarray Profiling Reveals
Distinct Circulating miRNAs in Aged Male and Female Mice Subjected to Poststroke Social Isolation. Neuromolecular Med, 23, 305-314.], [COPYRIGHT: 2021]
Identification of differentially expressed

miRNAs

in the

ipsilateral

hemisphere of Post-Stroke Isolated Mice
MiRNAs implicating the pathogenicity of stress-induced disorders have
increasingly been recognized in the brain (Popa et al., 2020) and in the circulation
(Banerjee et al., 2021). To investigate the role of miRNAs as a potential regulator
of microglial activation resulting in the downstream detrimental effects of poststroke SI; the miRNA abundance at three time points (Post-Stroke SI D1, D4, and
D27) was examined. This stratification process led us to identify potential miRNA
candidates that had differential expression over three different phases of SI which
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potentially addressed the effect of isolation on miRNA profiles within the brain in a
temporal manner. In the discovery phase, aged male mice were subjected to
ischemic stroke and the ipsilateral hemisphere was collected following three time
points of post-stroke SI D1, D4, and D27 in the corresponding housing conditions
for QIAGEN-based NGS analysis as shown in Figure 1.

Acclimation
Aged males (18-20 months)

Time (d)

-14

0

3

MCAO

Assign to housing

4

PH
SI

7

30

Brain (Ipsilateral Hemisphere) miRNA Sequencing
Post-stroke SI D1 (Acute Phase):
• N=4/ housing
Post-stroke SI D4 (Sub-acute Phase):
• N=4/ housing
Post-stroke SI D27 (Chronic Phase):
• N=4/ housing

Figure 1. Schematic of experimental design for miRNA identification and analysis.
Aged C57BL/6 male mice (18-20 months) were subjected to middle cerebral artery
occlusion (MCAO) and were randomly assigned three days post-reperfusion to SI
(individually housed) or continued pair housed conditions. At three distinct time
points of post-stroke SI D1 (Acute), D4 (Sub-acute), and D27 (chronic); mice were
euthanized, and the ipsilateral hemisphere were collected for further miRNA-based
NGS sequencing from QIAGEN and downstream bioinformatics.

Differentially expressed miRNAs with a threshold criterion of (FDR adjusted p <
0.05) were identified through the QIAGEN CLC Workbench to filter 10 hits across
all three points for appropriate fold change analysis as shown in Figure 2 a, b and
c.
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A

B
SI vs. PH in Post-stroke SI D1

miR-290a-5p
miR-7119-5p
miR-466I-3p
miR-7218-5p
miR-6943-3p
miR-5136
miR-1298-5p
miR-448-3p
miR-7004-5p
miR-6537-3p

SI vs. PH in Post-stroke SI D4
miR-449a-5p
miR-187-5p
miR-193b-3p
miR-21a-5p
miR-155-5p
miR-142a-5p
miR-21a-3p
miR-142a-3p
miR-142b
miR-10a-5p

-3 -2 -1 0

2

-4 -2 0 2 4 6 8

Fold change
(normalized to PH)

Fold change
(normalized to PH)

C

1

SI vs. PH in Post-stroke SI D27
miR-10b-5p
miR-205-5p
miR-224-5p
miR-7075-3p
miR-375-3p
miR-6537-5p
miR-144-3p
miR-451a
miR-6998-3p
miR-7118-3p
-5

0

5

10

Fold change
(normalized to PH)

Figure 2. Bioinformatics analysis of differential expressed miRNAs in post-stroke
SI compared to PH conditions across three time points.
(A, B, and C) highlight the significantly differential expressed miRNAs with a FC of
1 or higher for post-stroke socially isolated aged males at D1, D4, and D27,
respectively. Positive fold change indicates an upregulation in SI, while negative
fold change signifies a downregulation in SI.
Fold change was calculated based as a ratio from normalized transcripts per
million (TPM) of PH mice to TPM values of SI mice. Of the 10 differentially
expressed miRNAs identified within post-stroke SI D1 aged male mice, 4 (miR6537-5p, miR-7004-5p, miR-448-3p, miR-1298-5p, and miR-1298-5p) were
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upregulated and 6 (miR-5136, miR-6943-3p, miR-7128-3p, miR-466l-3p, miR7119-5p, and miR-290a-5p) were downregulated relative to pair housing. Fold
change analysis within the 10 miRNAs candidates identified from post-stroke SI
D4 mice revealed 7 (miR-10a-5p, miR-142b, miR-142a-3p, miR-21a-3p, miR142a-5p, miR-155-5p, and miR-21a-5p) were significantly upregulated in singly
housed male mice while 3 (miR-193b-3p, miR-187-5p, and miR-449a-5p) were
downregulated. Within the post-stroke SI D4 pool of candidate miRNAs, 3 of the 7
upregulated miRNAs belonged within the miR-142 family of miRNAs suggesting
their potential synergistic biological function. At the chronic phase of isolation at
post-stroke SI D27 mice, of the 10 differentially expressed miRNAs, 5 (miR-71183p, miR-6998-3p, miR-451a, miR-144-3p, and miR-6537-5p) were upregulated
and 5 (miR-375-3p, miR-7075-3p, miR-244-5p, miR-205-5p, and miR-10b-5p)
were downregulated based on our cutoff criteria of (FDR adjusted p < 0.05). Thus,
these results demonstrate that SI has distinctive effects upon the brain in a
temporal manner.
Construction of miRNA-mRNA interactional networks
In an effort to decipher the biological function of the identified miRNAs and to
elucidate the downstream pathway involvement of these filtered candidates,
mRNA genetic target analysis was performed incorporating an identification
platform of differentially expressed targets through the miRNET 2.0 target feature.
The differentially expressed miRNAs identified through the CLC Workbench
feature from QIAGEN were fed into miRNET 2.0 and the pool of predictive mRNA
targets were filtered utilizing a stringent criterion of 7 base points (bps) seed length
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and a significance level of (FDR adjusted p < 0.05) (data not shown).
Subsequently, 3 distinct miRNA-mRNA interactional networks were constructed
integrating all miRNAs filtered from the given cutoff criteria (p < 0.05) or lower
across the three time points of post-stroke SI as illustrated in Figure 3 a, b, and c
using the miRNET 2.0 characteristic feature. Island networks encompassing one
miRNA were not included in our analysis.

A

B

C
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Figure 3. miRNA–mRNA interaction networks and miRNA gene targets.
(A, B, and C) The differentially expressed miRNAs and their predicted mRNA
transcript targets are illustrated as networks across the three time points. Each
individual node represents a miRNA or mRNA. Hubs of the 3, 5, and 4 differentially
expressed miRNAs are shown in individual networks for Post-Stroke SI D1, D4,
and D27 respectively. Nodes interacting with the miRNA are highlighted in green
and individual target genes are highlighted in red.
The miRNA-mRNA networks showed that several mRNA targets are shared by
multiple differentially altered miRNAs at all three time points of post-stroke SI.
Following interaction analysis, miR-466i-3p was identified as a pivotal node within
the pool of miRNAs from post-stroke SI D1 mice indicating its role as a potential
regulator of all other miRNAs from same time point. More notably, miR-10a-5p and
miR-10b-5p were identified as a pivotal node across post-stroke SI D4 and D27,
respectively, indicating a potential synergistic role and common pathways of
involvement in the chronic stages of SI. In post-stroke SI D1 mice, miR-209a-5p
had the highest predicted targets followed by miR-466i-3p, and miR-448-3p.
Additionally, miR-10a-5p had the highest predicted targets followed by miR-1555p, miR-449a-5p, miR-21a-5p, and miR-142a-5p within post-stroke SI D4 mice. In
post-stroke SI D27 mice following interactional analysis, miR-10b-5p had the
highest predicted targets followed by miR-451a, miR-205-5p, and miR-144-3p.
The miR-10 family had the highest number of gene targets across the two time
points of post-stroke SI D4 and D27, suggesting similar downstream pathway
involvement and gene regulation. Among these pools of target mRNAs, a vast
number of them were identified as pivotal regulators of depression, neuroinflammatory processes, and microglial activation. Remaining miRNAs not found
within the interactional network did not have overlapping gene targets across the
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time points. As indicated, pivotal nodes among the networks were identified by
centrality of degree over the peripheral regions of interaction. Interactional
networks from post-stroke SI D1 and D27 had the relative same number of nodes
and interactions. In contrast, differentially expressed miRNAs identified within the
post-stroke SI D4 mice had the greatest number of nodes with higher gene
interactions relative to the other time points suggesting a greater change in the
overall pool of miRNAs within the same time point. Taken together following our
network analysis, miR-446i-3p, miR-10a-5p, and miR-10b-5p were found to be
crucial nodes within post-stroke SI D1, D4, and D27 groups respectively, that
interacted with the largest subset of genes and miRNAs.
KEGG and Reactome analyses of mRNAs targeted by the differentially
expressed miRNAs
Previous studies have shown that changes to environmental conditions and
stressors can alter miRNA profiles within specific tissues and lead to downstream
physiological changes (Miguel et al., 2020). Therefore, to examine the biological
relevance of these miRNA alterations we performed Kyoto Encyclopedia of Genes
and Genomes (KEGG) and Reactome analysis to further characterize their
downstream functions and to investigate the underlying bio-molecular pathways
(Lee et al., 2021). KEGG analysis revealed the top 50 signaling pathways within
all three time points, all significantly enriched (FDR adjusted p < 0.05) (Figure 4).
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Figure 4. KEGG Pathway analysis of the predicted mRNA gene transcripts
targeted by the differentially expressed miRNAs in the ipsilateral hemisphere of
post-stroke SI.
D1 (A and B), D4 (C and D), and D27 (E and F). The top 50 identified pathways in
post-stroke SI regulated the filtered miRNAs from interaction analysis were
analyzed by KEGG and are shown based on the number of entities (i.e., the
number of mRNA transcripts) involved. The * marks indicate pathways involved in
microglial-related immune activation.
More notably, post-stroke SI D1 miRNAs were involved in pathways of cell cycle,
RNA degradation, and calcium signaling pathways indicative of cell damage and
ischemic injury at the acute phase of stroke which dominated the effects of SI on
the miRNA profiles. The majority of the KEGG pathways identified within poststroke SI D4 had many pathways involved with microglial-related immune
activation that were not evident at the other time points. A few of the identified
pathways related to microglial activation were the PI3K-Akt signaling pathway, the
MAPK signaling pathway, the TNF signaling pathway, and the Jak-STAT signaling
pathway. Furthermore, post-stroke SI D27 miRNAs were those involved in
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pathways related to neurobehavioral signaling and metabolic function suggesting
the potential of the effect of SI on chronic behavioral impairment, cognitive
recovery, and energy expenditure. Some of these pathways involved with neurobehavioral and metabolic signaling included dopaminergic synapse, cholinergic
synapse, glutamatergic synapse, and thyroid hormone signaling pathway. This
significant difference between the time points suggests that the detrimental
phenotypes induced by post-stroke SI manifest distinctly within the host over time.
We further performed systemic enrichment analysis using the Reactome platform
to pinpoint putative mechanisms on the effect of post-stroke SI toward the host
through the miRNA changes observed. Reactome analysis revealed the top 50
signaling pathways within all three time points, all significantly enriched (FDR
adjusted p < 0.05) (Figure 5).
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Figure 5. Reactome Pathway analysis of the predicted mRNA gene transcripts
targeted by the differentially expressed miRNAs in the ipsilateral hemisphere of
post-stroke SI.
D1 (A and B), D4 (C and D), and D27 (E and F) The top 50 identified pathways in
post-stroke SI regulated the filtered miRNAs from interaction analysis were
analyzed by Reactome and are shown based on the number of entities (i.e., the
number of mRNA transcripts) involved. The * marks indicate pathways involved in
microglial-related immune activation.
Reactome analysis included a majority of pathways involved in microglial-related
immune activation within the altered miRNAs from post-stroke SI D4 mice. This
suggested a putative connection among the effects of SI toward a response. Some
of the identified putative pathways involved in microglial-related immune activation
were the family of signaling by FGFR, activated TLR4 signaling, toll-like receptor
cascade, and the family of PI3K cascades. In addition, Reactome analysis within
the pool of filtered miRNAs from post-stroke SI D27 included many pathways
involved in reparative mechanisms along with some pathways involved in
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microglial activation indicative of potential crosstalk among neuronal cellular
subtypes with other glial cells in the brain.
Post-Stroke SI Induces Microglial Activation
To validate our findings from our QIAGEN NGS and downstream pathway analysis
we focused on post-stroke SI D4 as miRNA candidates and pathways involved in
microglial activation were present across both enrichment analysis compared to
the other time points. Furthermore, previous literature has shown the importance
of the family of miR-10 miRNAs, a pivotal node identified across post-stroke SI D4
and D27, in regulating macrophage polarization within adipocyte tissue in models
of glucose intolerance (Cho et al., 2019). Additionally, the miR-142-5p family of
miRNAs, 3 of the 10 identified significantly differentially expressed targets within
post-stroke SI D4 regulate macrophage polarization through targeting suppressor
of cytokine signaling 1 (SOCS1) and prolonging signal transducer and activator of
transcription 6 (STAT6) phosphorylation to induce IL-4 and IL-13 production as
seen in a previous report (Su et al., 2015). In the validation phase, we examined
the expression levels of the top 2 up-/ down-regulated miRNAs (miR-10a-5p, miR142b, miR-187-5p, and miR-449a-5p) along with the candidate miRNAs that
belonged to the miR-142 family (miR-142a-3p and miR-142a-5p) as a validation
measure utilizing the QIAGEN NGS cohort of mice. As expected, miRNA-142a-3p
and miR-142a-5p were significantly upregulated in post-stroke socially isolated
mice as compared to paired house mice (Figure 6a and b). On the other hand,
miR-449a-5p was significantly downregulated in post-stroke socially isolated mice
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(Figure 6c). However, we didn’t any changes in miR-10a-5p and miR-187-5p
across the two housing conditions (Figure 6d and e).
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Figure 6. Validation of miRNA candidates within the ipsilateral hemisphere of the
brain in post-stroke SI D4 aged male mice.
(A, B, C, D, and E) The expression levels of miRNA candidates were examined
by real-time quantitative qPCR. miR-142a-3p and miRNA-142a-5p were
significantly upregulated in a coronal section of ipsilateral hemisphere of the brain
in post-stroke social isolation D4 aged male mice while miR-449a-5p was
significantly downregulated. No change was observed for miRNA-10a-5p and miR187-5p across the two housing conditions. Gene for U6 spliceosomal RNA was
used as an endogenous control, in which the unpaired student’s t-test was used.
The data are presented as the means ± SEM. n = 4 per group. *p < 0.05.

Multitude of studies have shown the predominant surface markers for the
identification of microglia are cluster of differentiation (CD) 45 (intermediate
expression), CD11b, Tmem119, and P2RY12; the according markers were used
to characterize microglial activation. Figure 7a shows the gating strategy used to
identify microglial cells within the brain. To assess microglial activation and
potentially identify “disease-associated microglia (DAM)” in our model of poststroke SI at D4, independent validation cohorts were set up and flow cytometry
was used to measure the expression level of Tmem119 and P2RY12 on microglial
cells. We found that 4 days of isolation post-stroke led to a significant
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downregulation of P2RY12 expression as a measure of median fluorescence
intensity (MFI) compared to the paired housed controls (Figure 7b), however no
change was observed in Tmem119 expression between the two groups (Figure
7c). Taken together, this suggests that SI may activate resting microglial cells to
deviate from homeostasis and further may have a differential effect on their
transcriptional signature due to their miRNA alterations.
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Figure 7. Post-stroke SI D4 induces microglial activation.
(A) Representative flow cytometry plots to identify microglia cell populations in the
ipsilateral hemisphere of aged post-stroke SI D4 male mice. CD45IntCD11b+ cells
in the ipsilateral hemisphere of post-stroke SI aged males were gated and
analyzed as microglia cells. An amine-reactive Zombie-Aqua viability stain was
used to identify live and dead cells. (B and C) Median fluorescence intensity (MFI)
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of P2RY12, as a measure of expression, in CD45IntCD11b+P2RY12+ cells showed
significant decrease in post-stroke SI D4 aged mice. MFI of Tmem119 in
CD45IntCD11b+Tmem119+ cells showed no change among the two housing
conditions post-stroke. MFI was reported as arbitrary fluorescence units [a.f.u]. (n
= 7-8/gp, unpaired student t test. The data are presented as the means ± SEM. *p
< 0.05).
Discussion
In this study, we have shown that post-stroke SI results in significant
alterations of miRNAs profiles in the brain. Furthermore, we have shown that poststroke SI can differentially effect miRNA profiles at differently among phases of SI
suggesting distinct downstream molecular pathways at play. This was further
corroborated by the putative interactional networks which showed different points
of regulation and gene targets across the three time points. Many of the identified
miRNA candidates in post-stroke SI D4 mice actively participated in the regulation
of microglial activation shown through KEGG and Reactome analysis. This was
further validated using qRT-PCR and flow cytometry as post-stroke SI D4 showed
a significant alteration of miRNA candidates and a significant downregulation of
P2RY12 expression, respectively. In this study, we determined that post-stroke SI
in aged male mice at the acute, sub-acute, and chronic phases have a potential to
influence the homeostatic miRNA profiles within the brain. These changes are
reflective of potential mechanisms that facilitate the detrimental effects of poststroke recovery and the exacerbate microglial activation, as SI is known to
contribute to poorer outcomes following ischemic stroke (Steptoe et al., 2013).
Moreover, several novel miRNAs candidates were identified in this study which
may potentially regulate the expression of key genes involved in either promoting
or worsening post-stroke recovery across housing conditions. This overview of
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candidate miRNAs serves as an initial step in identifying targetable molecules, at
the post-transcriptional level, to which give insight in potential downstream
detrimental effects of post-stroke SI toward the host.
Previous reports have shown that SI immediately after stroke can result in
the aberrant expression of miRNAs in the brain exacerbating cognitive impairment
and promoting the expression of pro-inflammatory cytokines (Antony et al., 2020,
Verma et al., 2018). However, the source of these pro-inflammatory cytokines as
a contributor to the overall inflammatory landscape were not investigated in the
study. This study was conducted to investigate the miRNAs that may potentially
be associated with microglial activation resulting in the production of these proinflammatory cytokines investigated in previous studies. Following our initial
exclusion criteria, 10 miRNAs were identified to be significantly differentially
expressed in SI compared to PH mice across all time points of post-stroke SI D1,
D4, and D27. Within post-stroke SI D1 mice, of the 10 identified differentially
expressed miRNAs, 6 miRNAs (miR-290a-5p, miR-7119-5p, miR-466i-3p, miR7218-5p, miR-6943-3p, and miR-5136) were downregulated while 4 miRNAs (miR1298-5p, miR-448-3p, miR-7004-5p, and miR-6537-3p) were upregulated in SI
compared to PH mice. In post-stroke SI D4 mice, 3 miRNAs (miR-449a-5p, miR187-5p, and miR-193b-3p) were downregulated while 7 miRNAs (miR-21a-5p,
miR-155-5p, miR-142a-5p, miR-21a-3p, miR-142a-3p, miR-142b, and miR-10a5p) were upregulated in SI as compared to PH mice. In addition, 3 of the 10
identified miRNAs were a part of the miRNA-142 family indicative of a downstream
synergic role toward the host. Within post-stroke SI D27 mice, 5 miRNAs (miR-
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10b-5p, miR-205-5p, miR-224-5p, miR-7075-3p, and miR-375-3p) were observed
to be significantly downregulated while 5 miRNAs (miR-6537-5p, miR-144-3p,
miR-451a, miR-6998-3p, and miR-7118-3p) were upregulated within SI mice. The
target finder feature within miRNET 2.0 was used to determine subsets of gene
targets which were putatively regulated by the identified candidate miRNAs
associated with post-stroke SI across the three time points (data not shown).
Following target prediction, interactional analysis was performed to investigate
how the identified pool of miRNAs in a given time point interacted among the pool
of miRNAs and their gene targets. Interactional analysis showed miR-466i-3p,
miR-10a-5p, and miR-10b-5p as central nodes for post-stroke SI D1, D4, and D27
mice, respectively. Central nodes were classified based on their degree of
targeting the largest subset of genes and putatively regulating the largest number
of miRNAs within the same network. More notably, across post-stroke SI D4 and
D27, miR-10a-5p and miR-10b-5p, both belonging to the miR-10-5p family, were
identified as central nodes suggesting a potential connective downstream gene
network toward the host during the subacute and chronic phases of post-stroke SI.
Sequencing studies from ischemic stroke models in mice have shown significant
alterations of miR-466i-3p in the brain (Lusardi et al., 2014). More recently, miR10-5p family of miRNAs has been shown to play an active role in regulating
macrophage polarization within adipocytes in mice models of glucose intolerance
(Cho et al., 2019) suggesting that differentially expressed miRNAs within the brain
in the sub-acute and chronic phases of post-stroke SI may play a role in microglial
activation. Further, the miRNA-10-5p family has also been shown to participate in
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exacerbating depression within the dorsolateral prefrontal cortex by playing a role
as an epigenetic modifier to genes that regulate the progression of major
depressive disorders in patients (Dwivedi, 2018). MiRNAs regulating microglial
activation following neuro-inflammation has been increasingly recognized (Guo et
al., 2019). This modulation suggests its potential of therapeutic use as animal
studies have shown the effective usage of agomiR/ antagomiR to target miRNA
changes (Li et al., 2021).
In order to characterize the biological functionality of the filtered miRNAs
from interactional analysis, two independent enrichment platforms were utilized,
KEGG and Reactome. As expected, candidate miRNAs identified from post-stroke
SI D1 mice were involved in pathways related to cell death and RNA degradation
suggestive of a more profound physiological effect from the ischemic injury as
compared to the alteration of the housing condition itself within the acute phase.
Across both KEGG and Reactome analysis of miRNAs identified within post-stroke
SI D4 mice, significant numbers of pathways were involved in microglial-related
immune activation activation, such as PI3K-Akt signaling, TNF signaling, JakSTAT signaling, and TLR signaling cascades. Numerous studies and through the
efforts of single cell sequencing of microglia in mice models of Alzheimer’s disease
(AD) and amyotrophic lateral sclerosis (ALS) have shown that this microglial
activation can be further characterized into distinct microglial subtypes having
differential effects towards the overall neuro-immune landscape and the long term
effects of cognition of the host (Deczkowska et al., 2018). Previous reports have
shown that these microglial subtypes have unique signatures of transcriptional and
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surface marker profiles (Bennett et al., 2018) which may be contributed by these
miRNA alterations being observed. Common surface markers such as Tmem119
and P2RY12 have been used to characterize this differentiation of microglia into
its subtypes (Bennett et al., 2016). Thus, future studies are warranted to
investigate the role of miRNAs in inflammation and the differentiation of microglial
subtypes. As characterizing microglial activation based on the alteration of
functional and transcriptional markers have been well documented in various
neuro-inflammation models (Honarpisheh et al., 2020, Bennett et al., 2018),
independent validation cohorts were used to investigate the detrimental effects of
post-stroke SI in the activation of microglia. We found that post-stroke SI D4 in
aged male mice caused a significant activation of microglia, as a measure of the
downregulation of P2RY12 expression (MFI) on (CD45IntCD11b+) microglia cells,
through flow cytometry. However, no change was observed with Tmem119
expression (MFI) on the similar cell type (CD45IntCD11b+) suggesting a potential
differential effect of SI toward the activation state of microglia. Further studies
investigating the role of miRNAs in regulating the differentiation of microglial
subtypes are warranted in the context of neuro-inflammation.
Previous reports have connoted the effects of post-stroke SI in cognitive
impairment and facilitating depressive-like phenotypes (Venna et al., 2014).
Similarly, KEGG and Reactome analysis from the miRNA candidates in post-stroke
SI D27 mice revealed many pathways involved in reparative mechanisms such as
cell cycle signaling along with pathways involved in learning, memory and
cognition. A few pathways involved in microglial activation similar to those found
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in post-stroke SI D4 were identified suggesting a prolonged presence of microglial
activation in the chronic phases of SI. Future studies are essential to characterize
the activation state of microglia at post-stroke SI D27. Recent reports have shown
that long term social stress or social isolation can result in depressive-like
phenotypes, anhedonia, and decreased urge of social interaction (Macdonald et
al., 2021, Shirenova et al., 2021, Corbett et al., 2019). Taken together, our study
shows that SI at the acute phase of D1 has no effect towards the host as ischemic
damage is predominant, the sub-acute phase of SI has a significant effect toward
the activation of microglia, and prolonged isolative conditions leads to the
emergence of depressive-like phenotypes in post-stroke SI D27.
Despite our comprehensive approach in identifying potential miRNA targets
and performing downstream target prediction/ pathway analysis a few limitations
exist. One of which pertains to the concept of mRNA target validation through
implementing luciferase assay since the target prediction in this study is putative.
Further, Tmem119 expression showed no significant change as compared to
P2RY12 expression within post-stroke SI D4 mice, further investigation examining
the relation of SI toward the specificity of P2RY12 change is warranted. Further
cytokine analysis is essential to characterize this activation state and its influence
toward the host neuro-immune landscape. As miRNAs from post-stroke SI D27
mice showed pathways involved in cognitive impairment, memory, and
depression; behavioral tests to capture potential cognitive deficits are essential at
the chronic phase of SI. Further, as work from our laboratory have shown that
miRNA profiles within the circulation of post-stroke SI mice are sexually dimorphic
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(Banerjee et al., 2021) and recent reports highlight the role of sex differences in
microglial activation (Liu et al., 2019), studies incorporating the biological variable
of sex are essential.
In summary, the analysis from this study provides a wide overview of the
miRNA alteration observed in the brain of post-stroke SI aged mice across three
time points. The concept of social stress, social defeat, and SI have been shown
to increase all-cause mortality, impair recovery, and exacerbate immune activation
following ischemic injury (Verma et al., 2014, Verma et al., 2018). However
standardized treatments options to alleviate the detrimental effects of SI are
extremely limited. Our study provides a new avenue in investigating the effects of
post-stroke SI toward the host at a post-transcriptional level. Our data supported
our initial hypothesis that post-stroke SI leads to a significant alteration of miRNA
profiles within the brain which may result in the activation of microglia that may be
regulated by particular classes of miRNAs in SI mice. Future work will focus on
modulating these miRNA changes through appropriate agomiR or antagomiR
treatments to mediate the detrimental effects we see from post-stroke SI. Thus,
the primary conclusion of this study is post-stroke SI significantly alters miRNA
profiles within the brain to facilitate the activation of microglia.
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